ArticleScientific reports2024
Fabrication of novel PVA loaded ZnO nanoparticles for anti-renal failure.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
X-ray diffraction (XRD), scanning electron microscopy (SEM) and transmission electron microscopy (TEM) were used to investigate the structural, surface and particles properties of a series of zinc oxides (ZnO) doped with polyvinyl alcohol (PVA) that were prepared using the sol-gel method. The results demonstrated that the crystallinity of the catalysts decreased as the PVA content increased beyond 5 PVA/ZnO. However, on raising the calcination temperature up to 500 °C, the average crystal size of the PVA/ZnO nanoparticles increased. Next Pyridine adsorption was used to measure the surface acidity of the catalysts, and the results showed that doping ZnO with PVA and raising the calcination temperature to 500 °C increased the catalyst's surface acidity. Furthermore, the data indicates that raising the ratio of the Brønsted to Lewis acid sites enhanced the catalytic activity for the synthesis of coumarin derivatives. We concluded that the structural and acidity characteristics of the catalysts under study had a significant impact on the catalytic activity. Furthermore, a study examining the biological activity of ZnO/PVA and pure ZnO revealed that 5PVA/ZnO performed the best in terms of improving the kidney functions of diabetic rats.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.